Peter Bellezza
Foot & Ankle Surgery · Bristol, CTNPI 1346660776
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (31.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Bone Support Inc. at 34.1% of the total. 2025 is the largest year on record at $4,147, more than ten times the $96 reported in 2019.
Across 51 payments — averaging $187.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bone Support Inc.$3K
- Kairos Surgical Inc$2K
- Stryker$2K
- Arthrex$1K
- Organogenesis Inc.$754
- Smith+Nephew$116
- plus $109 from 3 others
What the payments were for
- Consulting fees$3,00031%
- Travel & lodging$1,36614%
- Food & beverage$2,81929%
- Education$2,40025%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bone Support Inc. | 3 | $3,266 |
| Kairos Surgical Inc | 7 | $2,310 |
| Stryker | 18 | $1,672 |
| Arthrex | 6 | $1,358 |
| Organogenesis Inc. | 8 | $754 |
| Smith+Nephew | 6 | $116 |
| Acell, Inc. | 1 | $58 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $33 |
| Kerecis Limited | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CERAMENTBONE VOID FILLER$3,266
- CERAMENT G$3,266
- AUGMENT INJECTABLE$440
- PROstep$369
- AXS INFINITY LS$276
- PuraPly$216
- ALLOPURE$177
- CITREFIX$171
- PROPHECY$171
- PURAPLY WOUND MATRIX$125
- DISTAL EXTREMITIES IMPLANTS FOREFOOT PLATES & SCREWS PLANTAR PLATE$118
- PURAFORCE$110
How this compares
$9,585 in reported general payments places this provider in the 85th percentile of 89 foot & ankle surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 64 | $517 |
| Cephalexin | 71 | $375 |
| Oxycodone Hcl | 75 | $339 |
| Ammonium Lactate | 12 | $214 |
| Gabapentin | 47 | $191 |
| Clindamycin Hcl | 19 | $150 |
| Prednisone | 26 | $69 |
| Cyclobenzaprine Hcl | 11 | $51 |
| Tramadol Hcl | 11 | $17 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bristol
- Anthony BrockingtonBristol$5K
- Thomas McDonaldEnfield$241K
- Jossie AbrahamNorwalk$152K
- Gabriel GambardellaBloomfield$99K
- David CaminearHamden$47K
- James DejesusNaugatuck$40K
- William ProbascoFairfield$26K
- Adebola AdelekeMiddletown$24K
- Rachel AlbrightDarien$14K
- Paulina PiekarskaNorwalk$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.